Profil
Martin Everett worked as a Principal at Glaxo Smithkline Plc and the University of Birmingham.
He also worked as the Head-Research at MerLion Pharmaceuticals Pte Ltd.
Dr. Everett earned a doctorate degree from the University of Bristol in 1992 and an undergraduate degree from the University of Wales, Newport in 1987.
Anciens postes connus de Martin Everett
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Corporate Officer/Principal | - |
| University of Birmingham | Corporate Officer/Principal | - |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Directeur Technique/Scientifique/R&D | - |
Formation de Martin Everett
| University of Wales, Newport | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Commercial Services |
